Human iPSC-derived cardiomyocytes: A translational model to predict drug-induced cardiac arrhythmias and long-term toxicity
Poster Sep 25, 2017
R Kettenhofen, G Luerman, R Bucerius, I Kopljar, DJ Gallacher, A De Bondt, E Vlaminckx, I Van Den Wyngaert, HR Lu, H Bohlen
Human induced pluripotent stem cell (iPSC)-derived cardiomyocytes represent a promising model for in vitro prediction of cardiac arrhythmias. Currently, two commercially available hiPSC-derived cardioymocyte products - including Axiogenesis Cor.4U human cardiomyocytes - are validated in an international multi-coresite study inside the comprehensive in vitro Pro-arrhythmia (CiPA) consortium. This aims to change the paradigm of safety pharmacological assessment from the assessment of drug interaction with the hERG channel to a potentially clinically more relevant assay system using human iPSC-derived cardiomyocytes in MEA-, voltage- and calcium-sensitive dye recordings.
Besides CiPA, a variety of oncological drugs including tyrosine kinase and HDAC inhibitors have been reported to induce long-term cardiac toxicity in the clinic. Recent findings clearly show that Cor.4U cardioymocytes can be applied to a long-term impedance assay and the results from known drugs perfectly translate to the clinical observations.
The results shown here imply that iPSC-derived Cor.4U human cardioymocytes are a translational in vitro cell model for the prediction of clinically relevant drug-induced cardiac arrhythmias and long-term toxicity.
A New Method for Analyzing MSe/All Ions Fragmentation in Xenobiotic Metabolism StudiesPoster
During early drug discovery, the study of metabolism plays an essential role in determining which drug candidates move forward into development and later stages. As an alternative to traditional Data Dependent Acquisition (DDA), the use of MSE/All Ions Fragmentation (AIF) has become common in metabolite identification workflows for the analysis of metabolic hot spots. Here we present a solution for analysis of MSE/AlF in metID studies.READ MORE
Histone Deacetylase 6 (HDAC6) As A Therapeutic Target in Chronic Lymphocytic LeukemiaPoster
This study investigates the role of histone deacetylase 6 (HDAC6) in chronic lymphocytic leukemia and establishes it as a novel therapeutic target for the treatment of this disease.READ MORE
Magnetic-microcontact printing based ECM nano-patterning allows homogeneous controlling of cell growth and behaviorPoster
Magnetic – microcontact printing of extracellular matrix proteins (ECM) results in cell microarrays (CMA) showing homogeneous cell growth and attachment on defined patterns. This greatly reduces bias in the analysis of cell responses to toxins, drugs or other stimuli.READ MORE